NCT06858865View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 12, 2025

Primary Completion Date

August 14, 2025

Study Completion Date

August 14, 2025

Conditions

Primary Hypercholesterolaemia

Interventions

DRUG

AD-228A

AD-228A Oral Tablet

DRUG

AD-2281 and AD-2282

AD-2281 Oral Tablet + AD-2282 Oral Tablet

Trial Locations (1)

Unknown

H+ Yangji Hospital, Seoul

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY